Submit your comments on draft recommendations on accelerating innovations for #sicklecell from the Real-World Evidence Initiative’s Coordinated Registry Network Work Group by October 15: https://t.co/VRrl6lmSvZ #ConquerSCD
ASH RC is seeking comments on draft recommendations on accelerating innovations for #sicklecell from the Real-World Evidence Initiative’s Coordinated Registry Network Work Group. Submit your comments by October 15: https://t.co/VRrl6lmSvZ #ConquerSCD
Excited to present at #ASCOQLTY22: Time at Home among older AML patients.
Results:
1. Treatment burden is very high
2. Pts tx w/Intensive Induction lived longer, but most time was spent engaged in care
https://t.co/zmPyAkhE8r
Are you living with advanced or metastatic cancer? You may be eligible for the free UNC Lineberger HealthScore program. This is a research study which provides you with 6 months of health coaching to help improve the way you feel and meet your health-related needs.
I’m a hematologist, not a cardiologist, but all of this resonates. Great piece from @califf001 that describes optimal state (not suboptimization) for health care delivery. @ASHCollab
🚨*MUST READ* at @JCardFail out now:
Dr. Robert Califf (@califf001) with this thought-provoking & solution-oriented perspective piece
"The Ecosystem to Support People with Heart Failure"
👉https://t.co/LROr9eqQlm
@texhern@DCRINews @verilylifesci @dramyabernethy@DukeHFDoc
Clinical trials, @ASH_hematology abstracts, and 💰:
A brief 🧵
Few investigator-initiated clinical trials are completed without #industry funding.
For that reason, I'm extra proud of our phase 2 #Pregnyl for life-threatening #GVHD abstract:
https://t.co/i5QS1emIkT
Excited to be starting my own lab in the Division of Hematology @BrighamHeme. Thrilled that this will allow me to continue to work with the Myeloma group @DanaFarberNews.
Thx to @socmdm for the opportunity to present our work #SMDM21:
Advancing methods for analyzing and visualizing patient-level data from discrete choice experiments to inform shared decision-making about chemotherapy
@nlcrossnohere @jfpbridges @StephWheelerUNC @DReuland@bwoodmd
This is the best news ever… @califf001 to be nominated (again) to be Commissioner of @US_FDA; he did a remarkable job in an all to brief tenure. Has the vision, experience, and disposition to run the complex agency. And work to complete on what he did for RWE. @POTUS
Could not agree more with this critical point. New approaches needed to support and accelerate research as traditional structures are under significant strain.
Those who care about progress for patients and advances in treatment need to be aware of the staffing challenges in clinical research programs across the country - that can be marginally funded in the best of times - multiple strategies needed to support studies of new therapies
To improve clinical evidence generation, we need fundamental changes to how we conduct clinical trials. Decentralization & extending the reach of clinical investigations to the community, especially the historically underserved, are among the most promising approaches today.
#ASHKudos to our 2021 Exemplary Service Awardee: Donna S. Neuberg, ScD of @DanaFarber! Her dedication and service provide great value to us and to #hematology. Read more about her accomplishments: https://t.co/OikYg8lYwf | #ASHAwards